Stocks
Arena Pharmaceuticals, Inc.ARNA
NASDAQHealthcareBiotechnology$99.99+0.00%
Price as of · delayed, not real-time
Specializing in innovative therapies for inflammatory diseases, this biopharmaceutical firm gained attention for its pipeline of small-molecule drugs targeting immune and inflammatory disorders. Investors closely followed its clinical-stage candidates before its acquisition by Pfizer in 2022.
Market Cap: $052W Range: $45.50-$100.00
Congressional Interest in Arena Pharmaceuticals, Inc. (ARNA)
4 members of Congress have disclosed 11 trades in Arena Pharmaceuticals, Inc. (ARNA), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
11
Unique Politicians
4
Buys
3
Sells
8
Who in Congress Is Trading ARNA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-02-12 | John A. Yarmuth | buy | $1K-$15K |
| 2020-11-20 | Thomas R Carper | buy | $1K-$15K |
| 2020-11-05 | John A. Yarmuth | buy | $1K-$15K |
| 2020-04-07 | Kelly Loeffler | sell | $15K-$50K |
| 2020-02-26 | Kelly Loeffler | sell | $15K-$50K |
| 2020-02-24 | Kelly Loeffler | sell | $50K-$100K |
| 2020-02-10 | Kelly Loeffler | sell | $50K-$100K |
| 2020-02-07 | Kelly Loeffler | sell | $50K-$100K |
| 2020-02-06 | Kelly Loeffler | sell | $50K-$100K |
| 2020-02-05 | Kelly Loeffler | sell | $50K-$100K |
| 2010-03-08 | HOWARD L. BERMAN | sell | $500,000 |